How to buy Maravai LifeSciences Holdings stock
Learn how to easily invest in Maravai LifeSciences Holdings stock.
Maravai LifeSciences is planning an initial public offering (IPO) to raise up to $1.35 billion. The company is most well known for its mRNA and RNA products, which are used in vaccine development. Most notably, its CleanCap approach is being used in several vaccine trials for COVID-19, though it's too soon to tell if any of those particular vaccines will make it to market.
Here's what we know so far about the IPO, including how to buy in when the stock goes public.
How to buy shares in Maravai LifeSciences Holdings
- Choose a platform. If you're a beginner, our stock trading table below can help you choose.
- Open your account. Provide your personal information and sign up.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: in this case.
- Research stocks. The platform should provide the latest information available.
- Buy your stocks. Place a market order or limit order with your preferred number of shares. It's that simple.
Our top picks for buying Maravai LifeSciences Holdings stock
- $0 stock, option and ETF trading
- Free robo-advisor and CFP planning sessions
- Get up to $1,000 in stock when you fund a new account within 30 days
- Close stock and ETF options trades for $0
- Trading courses to learn options trading
- Get $100-$5,000 when you open and fund an account with $5,000 to $1,000,000+
- $0 stock, option and ETF trades
- Innovative social trading features
- FINDER EXCLUSIVE: Get a $25 bonus when you sign up and deposit $100
Is it a good time to buy Maravai LifeSciences Holdings stock?
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Share price volatility
Over the last 12 months, Maravai LifeSciences Holdings's shares have ranged in value from as little as 4.52 up to 16.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market ( average) beta is 1, while Maravai LifeSciences Holdings's is -0.112. This would suggest that Maravai LifeSciences Holdings's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Maravai LifeSciences Holdings has bucked the trend.
|1 week (2023-11-21)||3.85%|
|1 month (2023-10-28)||-17.68%|
|3 months (2023-08-28)||-50.44%|
|6 months (2023-05-28)||-61.12%|
|1 year (2022-11-28)||-64.37%|
|2 years (2021-11-28)||-87.66%|
|3 years (2020-11-28)||-82.44%|
|5 years (2018-11-28)||inf%|
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Buy Maravai LifeSciences Holdings stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is Maravai LifeSciences Holdings under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Maravai LifeSciences Holdings P/E ratio, PEG ratio and EBITDA
Maravai LifeSciences Holdings's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Maravai LifeSciences Holdings stocks trade at around 28x recent earnings.
However, Maravai LifeSciences Holdings's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.
Maravai LifeSciences Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is 122.5 million.
The EBITDA is a measure of a Maravai LifeSciences Holdings's overall financial performance and is widely used to measure a its profitability.
To put that into context you can compare it against similar companies.
Frequently asked questions
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
How to buy Floor-and-Decor stock
Steps to owning and managing FND, with 24-hour and historical pricing before you buy.
How to buy Southwest Gas stock
Steps to owning and managing SWX, with 24-hour and historical pricing before you buy.
How to buy Chime stock when it goes public
Everything we know about the Chime IPO, plus information on how to buy in.
How to buy Key Energy Services stock
Steps to owning and managing KEG, with 24-hour and historical pricing before you buy.
How to buy McDermott International stock
Steps to owning and managing MDR, with 24-hour and historical pricing before you buy.
How to buy Gen Digital stock
Steps to owning and managing GEN, with 24-hour and historical pricing before you buy.
How to buy Grail (GRAL) stock when it goes public
Everything we know about the Grail IPO, plus information on how to buy in.
How to buy Harley-Davidson stock
Steps to owning and managing HOG, with 24-hour and historical pricing before you buy.
How to invest in Energy Transfer
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
Ask an Expert